An Eighteen‐Membered Macrocyclic Ligand for Actinium‐225 Targeted Alpha Therapy-Reference-Cited by-同舟云学术

An Eighteen‐Membered Macrocyclic Ligand for Actinium‐225 Targeted Alpha Therapy

Published:2017-10-16 Issue:46 Volume:56 Page:14712-14717
ISSN:1433-7851
Container-title:Angewandte Chemie International Edition
language:en
Short-container-title:Angew. Chem. Int. Ed.

Author:

Thiele Nikki A.¹,Brown Victoria²,Kelly James M.³,Amor‐Coarasa Alejandro³,Jermilova Una²,MacMillan Samantha N.¹,Nikolopoulou Anastasia³,Ponnala Shashikanth³,Ramogida Caterina F.²,Robertson Andrew K. H.²,Rodríguez‐Rodríguez Cristina⁴,Schaffer Paul²,Williams Clarence³,Babich John W.³,Radchenko Valery²,Wilson Justin J.¹^ORCID

Affiliation:

1. Chemistry and Chemical Biology Cornell University Ithaca NY 14853 USA

2. Life Science Division, TRIUMF Vancouver BC V6T 2A3 Canada

3. Radiology Weill Cornell Medicine New York NY 10065 USA

4. Fac. of Pharmaceutical Sciences, Dept. of Physics and Astronomy and Centre for Comparative Medicine University of British Columbia Vancouver BC V6T 1W5 Canada

Funder

National Center for Advancing Translational Sciences

Division of Chemistry

Publisher

Wiley

Subject

General Chemistry,Catalysis

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/anie.201709532

Reference45 articles.

1. Radium-223 chloride: a potential new treatment for castration-resistant prostate cancer patients with metastatic bone disease

2. Treatment of Metastatic Bone Disease and the Emerging Role of Radium-223